Related Experiment Video
Updated: May 22, 2026

08:16
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
Published on: July 7, 2017
Quantitative microscopy in murine models of lung inflammation
Joseph Soltzberg1, Sarah Frischmann, Christiaan van Heeckeren
1Hawken School, Gates Mills Ohio, USA.
Analytical and Quantitative Cytology and Histology
|May 23, 2012
Summary
A new computational program quantifies lung inflammation in mouse models of asthma and cystic fibrosis (CF). This tool enhances the accuracy and reproducibility of assessing therapeutic interventions for respiratory diseases.
Area of Science:
- Pulmonary Medicine
- Translational Medicine
- Computational Pathology
Background:
- Asthma and cystic fibrosis (CF) research relies on animal models to study inflammation and remodeling.
- Current qualitative methods for assessing lung inflammation in these models introduce variability.
- Objective measurement is crucial for interpreting therapeutic intervention outcomes.
Purpose of the Study:
- To develop a quantitative method for measuring lung inflammation.
- To utilize murine models of chronic asthma and cystic fibrosis (CF).
- To improve the interpretation of therapeutic interventions in respiratory diseases.
Main Methods:
- Developed a quantitative computational program interfaced with Image Pro Microscopy.
- Automated the review process of lung sections for inflammation and pathophysiology.
- Applied the program to murine models of asthma and CF.
Main Results:
- The program accurately recapitulated data from manual point counting, bronchoalveolar lavage, and histology.
- Demonstrated low coefficients of variation and high reproducibility across slides and sections.
- Provided a sensitive and reproducible quantitative assessment of lung inflammation.
Conclusions:
- The developed microscopy program offers enhanced quantitative assessment of lung inflammation and structure.
- This tool can refine the interpretation of in vivo models for therapeutic interventions.
- Potential to accelerate the translation of findings into clinical settings for respiratory diseases.

